{
    "name": "romiplostim",
    "comment": "Rx",
    "other_names": [
        "Nplate"
    ],
    "classes": [
        "Hematopoietic Growth Factors",
        "Thrombopoietic Agents"
    ],
    "source": "https://reference.medscape.com/drug/nplate-romiplostim-342177",
    "pregnancy": {
        "common": [
            "Based on findings from animal reproduction studies, fetal harm may occur when administered to pregnant females ",
            "Limited available data in pregnant females are insufficient to inform a drug-associated risk of adverse developmental outcomes"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Drug crossed placenta, and adverse fetal effects included thrombocytosis, postimplantation loss, and an increase in pup mortality"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "No information available on presence of drug in human milk, effects on breastfed child, or on milk production",
            "Human IgG is present in human milk, but published data suggest that breast milk antibodies do not enter neonatal and infant circulation in substantial amounts",
            "Advise women not to breastfeed during treatment"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Progression from myelodysplastic syndromes (MDS) to acute myelogenous leukemia (AML) observed in adult clinical trials; not indicated for thrombocytopenia due to MDS or any cause of thrombocytopenia other than chronic ITP",
                "Thrombotic/thromboembolic complications may result from increased platelet counts; portal vein thrombosis reported; to minimize risk, in patients with ITP; do not use romiplostim in attempt to normalize platelet counts; follow dosage guidelines; use caution in patients with history of cerebrovascular disease",
                "Hyporesponsiveness or failure to maintain platelet response should prompt searching for causative factors, including neutralizing antibodies to romiplostim; discontinue if platelet count does not increase to level to avoid clinically important bleeding after 4 weeks of highest weekly dose (ie, 10 mcg/kg/week)",
                "Upon discontinuation of therapy, rebound thrombocytopenia and risk of bleeding may develop; monitor CBCs and platelet counts weekly for at least 2 weeks following discontinuation",
                "May increase risk for bone marrow reticulin formation or progression, which may improve upon discontinuation of therapy",
                "In absence of myelosuppression induced by acute exposure to radiation, administration might cause excessive increases in platelet counts and may cause thrombotic and thromboembolic complications"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Bronchitis",
            "percent": null
        },
        {
            "name": "Sinusitis",
            "percent": null
        },
        {
            "name": "Vomiting",
            "percent": null
        },
        {
            "name": "Arthralgia",
            "percent": null
        },
        {
            "name": "Myalgia",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "Upper respiratory tract infection",
            "percent": null
        },
        {
            "name": "Cough",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "Oropharyngeal pain",
            "percent": null
        }
    ]
}